Compounds useful for the treatment of cancer, compositions thereof and methods therewith

Details for Australian Patent Application No. 2003243587 (hide)

Owner Signal Pharmaceuticals, LLC.

Inventors Mercurio, Frank; McKenna, Jeffrey; Plantevin, Veronique; Xie, Weilin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003243587

PCT Number PCT/US03/18905

PCT Pub. Number WO2003/105774

Priority 10/463,009 16.06.03 US; 60/389,461 17.06.02 US

Filing date 17 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 28 February 2008

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 10/463,009 16.06.03 US; 60/389,461 17.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003243587

28 February 2008 Application Accepted

  Published as AU-B-2003243587

26 June 2008 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243588-Method for the fabrication of crystallizable resins and articles therefrom

2003243586-Front Suspension